(Total Views: 613)
Posted On: 08/13/2024 3:20:45 AM
Post# of 153820
Two quick questions for Ohm.
You wrote,
Last sentence above confuses me. Maybe a typo -- you meant "then" rather than "than"? But even if it is "then," would a Phase III that repeats the Phase II be necessary because this trial lacks scale?
You also mention that this would be a fourth-line treatment. Could an oncologist prescribe this combo off-label as an earlier treatment, or is that not done?
Guess these questions weren't that quick. Thanks, in any case.
You wrote,
Quote:
Trifluridine/tipiracil stops tumor cell reproduction so that could be helpful with leronlimab in a combination. Bevacizumab on the other hand inhibits VEGF (inhibiting tumor cell blood vessel growth) which leronlimab already does so it adds nothing. Since we will be combining with those drugs than certainly the FDA will insist we combine again in a phase 3.
Last sentence above confuses me. Maybe a typo -- you meant "then" rather than "than"? But even if it is "then," would a Phase III that repeats the Phase II be necessary because this trial lacks scale?
You also mention that this would be a fourth-line treatment. Could an oncologist prescribe this combo off-label as an earlier treatment, or is that not done?
Guess these questions weren't that quick. Thanks, in any case.
(6)
(0)
